BeyondMD Review

BeyondMD: a low-cost route to compounded GLP-1s, light on the fine print

BeyondMD is a no-frills telehealth clinic built around one clear pitch: get compounded semaglutide or tirzepatide into people's hands at a price that undercuts most of the big-name programs. If your priority is starting a GLP-1 quickly without paying over a thousand dollars a month for the brand pens, BeyondMD lands squarely in the value tier. The trade-off is transparency: this is a lean operation that publishes very little about how the program runs day to day, so you'll be taking some of it on trust until you're actually in the door.

How the pricing actually works

BeyondMD's headline is its semaglutide plan at $139 a month, which sits comfortably below the category median of $170. Tirzepatide, the newer dual-action molecule, runs higher, as it does everywhere, but is still priced to compete with the cheaper end of the market. Both figures are bundled rates: the company lists the medication, a consultation with a BeyondMD provider, and weight-loss coaching together rather than nickel-and-diming you with a separate membership fee on top. There's no teaser or first-month promo rate to lure you in and then jump, which is honestly refreshing — the price you see is roughly the price you keep paying.

One caveat worth flagging up front: BeyondMD's own site has shown slightly lower starting numbers than the rate on record here, so the exact figure can drift month to month. Treat $139 as the ballpark and confirm the live price at checkout before you commit.

The medications and how they're dispensed

Everything BeyondMD offers is compounded — meaning it's mixed by a compounding pharmacy rather than being the brand-name Wegovy, Ozempic, or Zepbound pen. That's the core reason the price is so low. You get the same active ingredients, semaglutide and tirzepatide, but in vials prepared by a pharmacy rather than in the manufacturer's auto-injector. For a lot of patients that distinction matters less than the monthly cost; for others it's a dealbreaker. Be clear-eyed about which camp you're in.

• Semaglutide — the lower-cost starting option, and the one BeyondMD leads with.
• Tirzepatide — confirmed available (verified through a patient account), priced higher but still competitive.
• No brand-name pens — if you specifically want FDA-approved Wegovy or Zepbound, this isn't the provider for that.

What genuinely sets BeyondMD apart

The real differentiator here is the bundle-and-price combination: coaching is folded in as a standard part of the program, not dangled as an optional paid extra the way several competitors do it. BeyondMD's program description lists weight-loss coaching and accountability right alongside the medication and provider consult, without the 'optional' asterisk you see elsewhere. For someone who wants a bit of hand-holding on habits and dosing — and who responds well to having an accountability check-in baked in — that's quiet added value at a price that's already low.

It also markets itself as a mainstream, broad-access option: the site says it serves most U.S. states and ships nationwide, so geography is rarely the thing that stops you from signing up.

Where BeyondMD falls short

The honest knock on BeyondMD is how little it discloses. It does not publish a specific list of the states it serves — you're told to email customer service to confirm availability for your address, which is more friction than a simple map would be. The program's finer details — refill cadence, what the coaching actually involves, refund or cancellation terms, which pharmacy compounds the medication — aren't spelled out publicly. There's no named compounding-pharmacy partner or accreditation on file in our record, which means you can't independently vet the sourcing the way you can with providers that name their pharmacy. None of that is a red flag on its own, but it does mean you're buying with less information than a cautious shopper would like.

Who should choose it

BeyondMD makes the most sense if you're a price-driven shopper who's already comfortable with compounded GLP-1s, wants both semaglutide and tirzepatide on the menu, and values having coaching included without paying extra. If the low monthly number is what gets you to actually start treatment, that's a real win.

Who should skip it

Skip it if you want brand-name medication, if you need to know your state is covered before you hand over any details, or if you're the type who wants every program term — pharmacy, refunds, dosing schedule — documented in writing up front. Providers that name their compounding pharmacy and publish their state list will give a more verification-minded patient more peace of mind. You can see how we weigh these factors in our scoring methodology.

The bottom line

BeyondMD is a legitimate budget pick for compounded GLP-1 therapy: aggressively priced, both major molecules available, and coaching thrown in. There's no FDA action on file against it, which is reassuring. But it asks you to accept thin public documentation in exchange for that low price — so confirm the current rate, your state's availability, and the pharmacy details directly before you enroll. For the right cost-conscious patient, it's a strong-value option; for anyone who wants everything verified in advance, a more transparent provider is the safer call.

Shopping around? Oak ($130/month) and Yucca Health ($146/month) are the nearest alternatives to BeyondMD in our rankings.